Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 166 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

 		ANCA Associated Vasculitis (AAV) Phase2 Japan
Singapore 		NCT06868290

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

 		Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors Phase1, Phase2 Singapore NCT06726148

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

 		Hidradenitis Suppurativa United Arab Emirates NCT06785675

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

 		Relapsing Multiple Sclerosis (RMS) Phase3 United States NCT06869785

Modifying PEST for Psoriatic Arthritis Screening

 		Plaque Psoriasis, Psoriatic Arthritis Na Canada NCT06382051

LATAM LOWERS LDL-C

 		Hypercholesterolaemia Phase4 Argentina
Brazil 		NCT06501443

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

 		Hidradenitis Suppurativa Phase3 Canada
United States 		NCT06840392

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

 		Generalized Myasthenia Gravis Phase3 United States NCT06744920

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

 		Chronic Myeloid Leukemia (CML) Phase2 France NCT06514534

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

 		Familial Hypercholesterolemia - Homozygous Phase3 China
United States 		NCT06597006